FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 58, Issue 11, 2009, Pages 1657-1662

  Pavlatou, Maria G ^a,b   Papastamataki, Maria ^a   Apostolakou, Filia ^a   Papassotiriou, Ioannis ^a   Tentolouris, Nicholas ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKOXY RADICAL; ANTIOXIDANT; HYDROPEROXIDE; LIPID PEROXIDE; METAL ION; OXYGEN RADICAL; PEROXY RADICAL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; C REACTIVE PROTEIN; FERRITIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; FEMALE; FENTON REACTION; FREE OXYGEN RADICAL DEFENSE TEST; FREE OXYGEN RADICAL TEST; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; ALGORITHM; BLOOD; BODY MASS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

AGED; ALGORITHMS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 70449728062     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.022     Document Type: Article

References (37)

1. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., and Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem, 52 (2006) 601-623
2. Piconi L., Quagliaro L., and Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 41 (2003) 1144-1149
3. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19 (1996) 257-267
4. Davies K.J. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61 (1995) 1-31
5. Maritim A.C., Sanders R.A., and Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17 (2003) 24-38
6. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 49 2, Suppl 1 (2000) 27-29
7. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48 (1999) 1-9
8. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
9. Chang K.C., Chung S.Y., Chong W.S., Suh J.S., Kim S.H., Noh H.K., et al. Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats. J Pharmacol Exp Ther 266 (1993) 992-1000
10. Young I.S., Tate S., Lightbody J.H., McMaster D., and Trimble E.R. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 18 (1995) 833-840
11. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Meth Enzymol 186 (1990) 1-85
12. Saxena A.K., Srivastava P., Kale R.K., and Baquer N.Z. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 45 (1993) 539-542
13. McLennan S.V., Heffernan S., Wright L., Rae C., Fisher E., Yue D.K., et al. Changes in hepatic glutathione metabolism in diabetes. Diabetes 40 (1991) 344-348
14. Ceriello A., and Sechi L.A. Management of cardiovascular risk in diabetic patients: evolution or revolution?. Diabetes Nutr Metab 15 (2002) 121-127
15. Mantovani G., Maccio A., Gramignano G., Lusso M.R., Massa E., Astara G., and Serpe R. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 13 (2004) 1651-1659
16. Abramson J.L., Jones D.P., Ashfaq S., et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 178 (2005) 115-121
17. Gramignano G., Madeddu C., Massa E., Serpe R., Deiana L., Lamonica G., et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 22 (2006) 136-145
18. Blomgren K., and Hagberg H. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 40 (2006) 388-397
19. Crimi E., Sica V., Slutsky A.S., Zhang H., Williams-Ignarro S., Ignarro L.J., et al. The role of oxidative stress in adult critical care. Free Radic Biol Med 40 (2006) 398-406
20. Cutler R.G., Plummer J., Chowdhury K., and Heward C. Oxidative stress profiling: part II. Theory, technology, and practice. Ann N Y Acad Sci 1055 (2005) 136-158
21. Medina J., and Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 65 (2005) 2445-2461
22. Sachidanandam K., Fagan S.C., and Ergul A. Oxidative stress and cardiovascular disease: antioxidants and unresolved issues. Cardiovasc Drug Rev 23 (2005) 115-132
23. Terman A., and Brunk U.T. Oxidative stress, accumulation of biological "garbage," and aging. Antioxid Redox Signal 8 (2006) 197-204
24. Garelnabi M.O., Brown W.V., and Le N.A. Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clin Biochem 41 (2008) 1250-1254
25. Gopaul N.K., Anggard E.E., Mallet A.I., Betteridge D.J., Wolff S.P., and Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 368 (1995) 225-229
26. Davi G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99 (1999) 224-229
27. Mori T.A., Dunstan D.W., Burke V., Croft K.D., Rivera J.H., Beilin L.J., et al. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 48 (1999) 1402-1408
28. Mori T.A., Puddey I.B., Burke V., Croft K.D., Dunstan D.W., Rivera J.H., et al. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep 5 (2000) 45-46
29. Altomare E., Vendemiale G., Chicco D., Procacci V., and Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabetes Metab 18 (1992) 264-271
30. Ceriello A., Quagliaro L., Catone B., Pascon R., Piazzola M., Bais B., et al. Role of hyperglycemia in nitrotyrosine post-prandial generation. Diabetes Care 25 (2002) 1439-1443
31. Ceriello A. Nitrotyrosine: new findings as a marker of post-prandial oxidative stress. Int J Clin Pract Suppl (2002) 51-58
32. Collins A.R., Raslova K., Somorovska M., Petrovska H., Ondrusova A., Vohnout B., et al. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med 25 (1998) 373-377
33. Kanauchi M., Nishioka H., and Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91 (2002) 327-329
34. Nishikawa T., Sasahara T., Kiritoshi S., Sonoda K., Senokuchi T., Matsuo T., et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26 (2003) 1507-1512
35. Hinokio Y., Suzuki S., Hirai M., Chiba M., Hirai A., and Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42 (1999) 995-998
36. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., and Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 Suppl 1 (2004) IV.6-IV.19
37. Harris M.T., Davis W., Le N.A., Eggleston B., Austin G., Moussa M., et al. Free oxygen radicals in whole blood correlate strongly with high-sensitive C-reactive protein. J Clin Lipidiol 1 (2007) 593-598